期刊文献+

促红细胞生成素B螺旋结构缩氨酸对大鼠心肌缺血损伤的影响

The cardioprotective effect of a small nonerythropoietic helix B surface peptide based upon erythropoietin structure on heart ischemic myocardial damage in rat
下载PDF
导出
摘要 目的探讨促红细胞生成素(rhEPO)B螺旋结构缩氨酸(pHBP)对大鼠心肌缺血损伤的影响及其机制。方法采用结扎冠状动脉前降支的方法建立大鼠急性心肌梗死(AMI)模型。90只大鼠随机分为四组:假手术组(A组,n=10)、AMI组(C组,n=20)、rhEPO组(G组,n=30)和pHBP组(E组,n=30)。建模后注射rhEPO、pHBP,24h后通过TCC染色测量MI面积。术后3、24h,Western blot法检测信号转导子与转录激活子3(STAT3)蛋白表达。8周后,通过超声心动图测量左心室舒张期末容积(LVEDV)、左心室收缩期末容积(LVESV)和左心室射血分数(EF)。结果与C组比较,E、G组MI面积明显减小(P<0.05)。与A组比较,E、G组STAT3蛋白表达明显增高(P<0.05)。与A组比较,E组和G组LVEDV和LVESV明显升高,EF明显降低(P<0.01)。与C组比较,E组和G组LVEDV和LVESV明显降低,EF明显升高(P<0.05)。结论 pHBP在大鼠心肌缺血损伤中具有心脏保护作用,其保护机制可能与其抑制心肌细胞凋亡和促进新生血管形成有关。 Objective To investigate the protective effects of a small nonerythropoietic helix B surface peptide based upon erythropoietin structure on heart ischemic myocardial damage in the rat.Methods Rat models of AMI which were built by ligating the left anterior descending coronary artery.Ninty rats were randomly divided into sham-operated group(group A,n=10),control group (group C,n=20),rhEPO group(group G,n=30) and pHBP treatment group(group E,n=30).After establiblishment of experiment of model,rats were given an injection of rhEPO,pHBP,the myocardial infarction area was evaluated by TCC dyeing after 24 hours; After 3 hours,24 hours of treatment,the expression of STAT3 was analysized through by Western blot; we assessed the LV end-diastolic volume (EDV),LV end-systolic volume(ESV),LV ejection fraction(EF%) of the rat by echocardiography after 8 weeks.Results The myocardial infarct size of the group G and E was decreased significantly than group C(P<0.05).Compared with group A,the expression of STAT3 was increased significantly in group E and G(P<0.05).Compared with group A,the LVEDV and LVESV were increased obviously,the EF was decreased significantly in group E and G (P<0.05).Compared with group C,the LVEDV and LVESV were decreased and the EF was increased significantly in group E and G (P<0.05).Conclusion pHBP has a cadioprotective effect on heart ischemic damage.The protective mechanism may be related to the function of inhibition of myocardial cell apoptosis and inducing neovascularisation.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2014年第8期801-803,共3页 Journal of Clinical Anesthesiology
基金 南昌市科技局科技计划项目(洪科发计字[2013]210号第30项)
关键词 促红细胞生成素B螺旋结构缩氨酸 心肌缺血 信号转导子与转录激活子3 Pyroglutamate helix B surface peptide Myocardial ischemia STAT3
  • 相关文献

参考文献10

  • 1Joyeux-Faure M.Cellular protection by erythropoietin:new therapeutic implications? J Pharmacol Exp Ther,2007,323(3):759-762.
  • 2Brines M,Cerami A.Erythropoietin mediated tissue protection:reducing collateral damage from the primary injury responses.J Intern Med,2008,264(5):405-432.
  • 3Bogoyevitch MA.An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.Cardiovasc Res,2004,63(2):208-216.
  • 4Riksen NP,Hausenloy DJ,Yellon DM.Erythropoietin:ready for prime-time cardioprotection.Trends Pharmacol Sci,2008,29(5):258-267.
  • 5Lippi G,Franchini M,Favaloro EJ.Thrombotic complications of erythropoiesis-stimulating agents.Semin Thromb Hemost,2010,36(5):537-549.
  • 6Brines M,Patel NS,Villa P,et al.Nonerythropoietic,tissue-protective peptides derived from the tertiary structure of erythropoietin.Proc Natl Acad Sci U S A,2008,105(31):10925-10930.
  • 7Burger D,Xenocostas A,Feng QP.Molecular basis of cardioprotection by erythropoietin.Curr Mol Pharmacol,2009,2(1):56-69.
  • 8秦晓毅,卢新政.STAT3与心肌重构[J].国际心血管病杂志,2012,39(1):22-24. 被引量:3
  • 9钟敏,肖建斌,周娜,招伟贤.远程预处理对心肌缺血-再灌注损伤的保护作用[J].临床麻醉学杂志,2011,27(11):1107-1109. 被引量:1
  • 10Ahmet I,Tae HJ,Juhaszova M,et al.A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.Mol Med,2011,17(3 4):194-200.

二级参考文献13

  • 1施节娟,吕国义,邓迺封.远程预缺血的心肌保护机制[J].国际麻醉学与复苏杂志,2006,27(3):182-185. 被引量:2
  • 2Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet, 2009, 374:1557 -1565.
  • 3Goodman MD, Koch SE, Afzal MR, et al. STAT subtype specificity and ischemic preconditioning in mice: is STAT-3 enough? Am J Physiol Heart Circ Physiol, 2011, 300: H522-526.
  • 4Barry SP, Townsend PA, Latchman DS, et al. Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med, 2007, 13: 82-89.
  • 5Bφtker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet, 2010, 375: 727-734.
  • 6Rahman IA, Mascaro JG, Steeds RP, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation, 2010, 122: S53-59.
  • 7Xuan YT, Guo Y, Han H, et al. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A, 2001,98:9050-9055.
  • 8Bolli R, Stein AB, Guo Y, et al. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol, 2011, 50: 589-597.
  • 9Hattori R, Maulik N, Otani H, et al. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol, 2001, 33: 1929-1936.
  • 10Smith RM, Suleman N, Lacerda L, et al. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res, 2004,63 : 611-616.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部